{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:48:28Z","timestamp":1760215708716},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,11,6]],"date-time":"2010-11-06T00:00:00Z","timestamp":1289001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s10096-010-1102-0","type":"journal-article","created":{"date-parts":[[2010,11,5]],"date-time":"2010-11-05T16:11:44Z","timestamp":1288973504000},"page":"415-422","source":"Crossref","is-referenced-by-count":18,"title":["Lipid peroxidation products as potential bioindicators of Lyme arthritis"],"prefix":"10.1007","volume":"30","author":[{"given":"W.","family":"\u0141uczaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Moniuszko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rusak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Pancewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Zajkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Skrzydlewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,6]]},"reference":[{"key":"1102_CR1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM200107123450207","volume":"345","author":"AC Steere","year":"2001","unstructured":"Steere AC (2001) Lyme disease. N Engl J Med 345:115\u2013125","journal-title":"N Engl J Med"},{"key":"1102_CR2","first-page":"454","volume":"21","author":"ES Asch","year":"1994","unstructured":"Asch ES, Bujak DI, Weiss M, Peterson MG, Weinstein A (1994) Lyme disease: an infectious and postinfectious syndrome. J Rheumatol 21:454\u2013461","journal-title":"J Rheumatol"},{"key":"1102_CR3","first-page":"1230","volume":"7","author":"SA Pancewicz","year":"2001","unstructured":"Pancewicz SA, Skrzydlewska E, Hermanowska-Szpakowicz T, Zajkowska JM, Kondrusik M (2001) Role of reactive oxygen species (ROS) in patients with erythema migrans, an early manifestation of Lyme borreliosis. Med Sci Monit 7:1230\u20131235","journal-title":"Med Sci Monit"},{"key":"1102_CR4","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.4049\/jimmunol.165.11.6532","volume":"165","author":"M Uesugi","year":"2000","unstructured":"Uesugi M, Yoshida K, Jasin HE (2000) Inflammatory properties of IgG modified by oxygen radicals and peroxynitrite. J Immunol 165:6532\u20136537","journal-title":"J Immunol"},{"key":"1102_CR5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0891-5849(91)90192-6","volume":"11","author":"H Esterbauer","year":"1991","unstructured":"Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81\u2013128","journal-title":"Free Radic Biol Med"},{"key":"1102_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/v93-001","volume":"71","author":"LRC Barclay","year":"1993","unstructured":"Barclay LRC (1993) Quantitative studies of peroxidation, antioxidant action, partitioning and oxidative stress. Can J Chem 71:1\u201316","journal-title":"Can J Chem"},{"key":"1102_CR7","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1096\/fj.04-2330rev","volume":"18","author":"P Montuschi","year":"2004","unstructured":"Montuschi P, Barnes PJ, Roberts LJ 2nd (2004) Isoprostanes: markers and mediators of oxidative stress. FASEB J 18:1791\u20131800","journal-title":"FASEB J"},{"key":"1102_CR8","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.1073\/pnas.87.23.9383","volume":"87","author":"JD Morrow","year":"1990","unstructured":"Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ 2nd (1990) A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87:9383\u20139387","journal-title":"Proc Natl Acad Sci USA"},{"key":"1102_CR9","doi-asserted-by":"crossref","first-page":"15533","DOI":"10.1074\/jbc.R700047200","volume":"283","author":"GL Milne","year":"2008","unstructured":"Milne GL, Yin H, Morrow JD (2008) Human biochemistry of the isoprostane pathway. J Biol Chem 283:15533\u201315537","journal-title":"J Biol Chem"},{"key":"1102_CR10","doi-asserted-by":"crossref","first-page":"13381","DOI":"10.1073\/pnas.96.23.13381","volume":"96","author":"H Li","year":"1999","unstructured":"Li H, Lawson JA, Reilly M, Adiyaman M, Hwang S-W, Rokach J, FitzGerald GA (1999) Quantitative high performance liquid chromatography\/tandem mass spectrometric analysis of the four classes of F2-isoprostanes in human urine. Proc Natl Acad Sci USA 96:13381\u201313386","journal-title":"Proc Natl Acad Sci USA"},{"key":"1102_CR11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0021-9673(95)00959-0","volume":"729","author":"D Londero","year":"1996","unstructured":"Londero D, Lo Greco P (1996) Automated high-performance liquid chromatographic separation with spectrofluorometric detection of a malondialdehyde\u2013thiobarbituric acid adduct in plasma. J Chromatogr A 729:207\u2013210","journal-title":"J Chromatogr A"},{"key":"1102_CR12","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1248\/cpb.34.1694","volume":"34","author":"K Yoshino","year":"1986","unstructured":"Yoshino K, Matsuura T, Sano M, Saito SCh, Tomita I (1986) Fluorometric liquid chromatographic determination of aliphatic aldehydes arising from lipid peroxides. Chem Pharm Bull 34:1694\u20131700","journal-title":"Chem Pharm Bull"},{"key":"1102_CR13","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1194\/jlr.M300146-JLR200","volume":"44","author":"A Bradford","year":"2003","unstructured":"Bradford A, Atkinson J, Fuller N, Rand RP (2003) The effect of vitamin E on the structure of membrane lipid assemblies. J Lipid Res 44:1940\u20131945","journal-title":"J Lipid Res"},{"key":"1102_CR14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0891-5849(96)00128-1","volume":"21","author":"M Kinter","year":"1996","unstructured":"Kinter M, Roberts RJ (1996) Glutathione consumption and glutathione peroxidase inactivation in fibroblast cell lines by 4-hydroxy-2-nonenal. Free Radic Biol Med 21:457\u2013462","journal-title":"Free Radic Biol Med"},{"key":"1102_CR15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.plipres.2003.10.001","volume":"43","author":"Y Dotan","year":"2004","unstructured":"Dotan Y, Lichtenberg D, Pinchuk I (2004) Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog Lipid Res 43:200\u2013227","journal-title":"Prog Lipid Res"},{"key":"1102_CR16","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1194\/jlr.R900004-JLR200","volume":"50","author":"MW Buczynski","year":"2009","unstructured":"Buczynski MW, Dumlao DS, Dennis EA (2009) Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology. J Lipid Res 50:1015\u20131038","journal-title":"J Lipid Res"},{"key":"1102_CR17","doi-asserted-by":"crossref","first-page":"21599","DOI":"10.1074\/jbc.M109.003822","volume":"284","author":"VA Blaho","year":"2009","unstructured":"Blaho VA, Buczynski MW, Brown CR, Dennis EA (2009) Lipidomic analysis of dynamic eicosanoid responses during the induction and resolution of Lyme arthritis. J Biol Chem 284:21599\u201321612","journal-title":"J Biol Chem"},{"key":"1102_CR18","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1074\/jbc.M307137200","volume":"279","author":"H Yin","year":"2004","unstructured":"Yin H, Morrow JD, Porter NA (2004) Identification of a novel class of endoperoxides from arachidonate autoxidation. J Biol Chem 279:3766\u20133776","journal-title":"J Biol Chem"},{"key":"1102_CR19","doi-asserted-by":"crossref","first-page":"16720","DOI":"10.1074\/jbc.M300604200","volume":"278","author":"H Yin","year":"2003","unstructured":"Yin H, Havrilla CM, Gao L, Morrow JD, Porter NA (2003) Mechanisms for the formation of isoprostane endoperoxides from arachidonic acid. \u201cDioxetane\u201d intermediate versus beta-fragmentation of peroxyl radicals. J Biol Chem 278:16720\u201316725","journal-title":"J Biol Chem"},{"key":"1102_CR20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1081\/DMR-100101910","volume":"1","author":"JD Morrow","year":"1999","unstructured":"Morrow JD, Chen Y, Brame CJ, Yang J, Sanchez SC, Xu J, Zackert WE, Awad JA, Roberts LJ (1999) The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation. Drug Metab Re 1:117\u2013139","journal-title":"Drug Metab Re"},{"key":"1102_CR21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1388-1981(00)00119-0","volume":"1488","author":"S Nigam","year":"2000","unstructured":"Nigam S, Schewe T (2000) Phospholipase A2s and lipid peroxidation. Biochim Biophys Acta 1488:167\u2013181","journal-title":"Biochim Biophys Acta"},{"key":"1102_CR22","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/art.23371","volume":"58","author":"VA Blaho","year":"2008","unstructured":"Blaho VA, Mitchell WJ, Brown CR (2008) Arthritis develops but fails to resolve during inhibition of cyclooxygenase 2 in a murine model of Lyme disease. Arthritis Rheum 58:1485\u20131495","journal-title":"Arthritis Rheum"},{"key":"1102_CR23","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0301-0082(95)00016-O","volume":"46","author":"H Katsuki","year":"1995","unstructured":"Katsuki H, Okuda S (1995) Arachidonic acid as a neurotoxic and neurotrophic substance. Prog Neurobiol 46:607\u2013636","journal-title":"Prog Neurobiol"},{"key":"1102_CR24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00726-005-0229-2","volume":"29","author":"SA Coolen","year":"2005","unstructured":"Coolen SA, van Buuren B, Duchateau G, Upritchard J, Verhagen H (2005) Kinetics of biomarkers: biological and technical validity of isoprostanes in plasma. Amino Acids 29:429\u2013436","journal-title":"Amino Acids"},{"key":"1102_CR25","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1182\/blood-2008-11-186312","volume":"113","author":"JM Foulks","year":"2009","unstructured":"Foulks JM, Marathe GK, Michetti N, Stafforini DM, Zimmerman GA, McIntyre TM, Weyrich AS (2009) PAF-acetylhydrolase expressed during megakaryocyte differentiation inactivates PAF-like lipids. Blood 113:6699\u20136706","journal-title":"Blood"},{"key":"1102_CR26","doi-asserted-by":"crossref","first-page":"S255","DOI":"10.1194\/jlr.R800024-JLR200","volume":"50","author":"TM McIntyre","year":"2009","unstructured":"McIntyre TM, Prescott SM, Stafforini DM (2009) The emerging roles of PAF acetylhydrolase. J Lipid Res 50:S255\u2013S259","journal-title":"J Lipid Res"},{"key":"1102_CR27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s100380200009","volume":"47","author":"S Ito","year":"2002","unstructured":"Ito S, Noguchi E, Shibasaki M, Yamakawa-Kobayashi K, Watanabe H, Arinami T (2002) Evidence for an association between plasma platelet-activating factor acetylhydrolase deficiency and increased risk of childhood atopic asthma. J Hum Genet 47:99\u2013101","journal-title":"J Hum Genet"},{"key":"1102_CR28","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1164\/ajrccm.159.3.9807093","volume":"159","author":"N Satoh","year":"1999","unstructured":"Satoh N, Asano K, Naoki K, Fukunaga K, Iwata M, Kanazawa M, Yamaguchi K (1999) Plasma platelet-activating factor acetylhydrolase deficiency in Japanese patients with asthma. Am J Respir Crit Care Med 159:974\u2013979","journal-title":"Am J Respir Crit Care Med"},{"key":"1102_CR29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10557-008-6133-8","volume":"23","author":"DM Stafforini","year":"2009","unstructured":"Stafforini DM (2009) Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2). Cardiovasc Drugs Ther 23:73\u201383","journal-title":"Cardiovasc Drugs Ther"},{"key":"1102_CR30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1074\/jbc.M608975200","volume":"282","author":"H Yin","year":"2007","unstructured":"Yin H, Gao L, Tai H-H, Murphey LJ, Porter NA, Morrow JD (2007) Urinary prostaglandin F2\u03b1 is generated from the isoprostane pathway and not the cyclooxygenase in humans. J Biol Chem 282:329\u2013336","journal-title":"J Biol Chem"},{"key":"1102_CR31","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1172\/JCI107987","volume":"55","author":"JC Fr\u00f6lich","year":"1975","unstructured":"Fr\u00f6lich JC, Wilson TW, Sweetman BJ, Smigel M, Nies AS, Carr K, Watson JT, Oates JA (1975) Urinary prostaglandins. Identification and origin. J Clin Invest 55:763\u2013770","journal-title":"J Clin Invest"},{"key":"1102_CR32","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/ard.60.6.627","volume":"60","author":"S Basu","year":"2001","unstructured":"Basu S, Whiteman M, Mattey DL, Halliwell B (2001) Raised levels of F2-isoprostanes and prostaglandin F2\u03b1 in different rheumatic diseases. Ann Rheum Dis 2001 60:627\u2013631","journal-title":"Ann Rheum Dis 2001"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-010-1102-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-010-1102-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-010-1102-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:34:22Z","timestamp":1559122462000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-010-1102-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,6]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["1102"],"URL":"https:\/\/doi.org\/10.1007\/s10096-010-1102-0","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,6]]}}}